Dr. Andreas Hahn
Vita
Graduated as physicist from Oxford University, UK
29 years in medical devices, 25 years in leading roles in various organizations
Corporate VP, directing Ottobock clinical research activities globally.
3 times winner of the AOPA Thranhardt Award
Program Items
Full-body neuromodulation is an innovative, rapidly developing additive approach to the treatment of spastic movement disorders and pain induced by spasticity. A new medical device is presented to the participants. They learn details about the underlying functional principle and gain insights into the current state of research results in this very rapidly developing field. Experiences from clinical practice complete the presentation.
Microprocessor-controlled stance and swing phase orthoses contribute significantly to improving the quality of life for patients with lower limb paralysis. This experience, which is known from everyday use, is strikingly confirmed by the latest clinical evidence. Participants learn about significant, clinically relevant improvements in the risk of falling, number of falls, mobility and quality of life in an international multi-centre, randomised crossover study with a cohort of 108 patients.